Baxter International
Baxter International was founded in 1931 and is headquartered in Deerfield, US
Report incorrect company information
Key People/Management at Baxter International
José Almeida
Chairman, President and Chief Executive Officer
John Forsyth
Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
James Gavin
Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
Munib Islam
Partner and Head of Equities Research, Third Point LLC
Michael Mahoney
Chairman, President and Chief Executive Officer, Boston Scientific Corporation
Cathy Smith
Executive Vice President and Chief Financial Officer, Target Corporation
Report incorrect company information
Baxter International Office Locations
Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations
Deerfield, US (HQ)
One Baxter Parkway
Report incorrect company information
Baxter International Financials and Metrics
Baxter International Financials
Baxter International's revenue was reported to be $10.16 b in FY, 2016 which is a 2% increase from the previous period.
| USD | |
|---|---|
Revenue (Q2, 2017) | 2.6 b |
Gross profit (Q2, 2017) | 1.1 b |
Gross profit margin (Q2, 2017), % | 43.4% |
Net income (Q2, 2017) | 265 m |
EBIT (Q2, 2017) | 339 m |
Market capitalization (20-Apr-2018) | 37.2 b |
Cash (30-Jun-2017) | 3.8 b |
Baxter International's current market capitalization is $37.2 b.
Annual
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Revenue | 10 b | 10.2 b |
Revenue growth, % | (40%) | 2% |
Cost of goods sold | 5.8 b | 6.1 b |
Gross profit | 4.1 b | 4.1 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.8 b | 4 b | 4.3 b | 4.2 b | 3.8 b | 3.9 b | 2.5 b | 2.4 b | 2.6 b | 2.6 b | 2.5 b | 2.6 b |
Cost of goods sold | 1.8 b | 2 b | 2.2 b | 2.1 b | 2 b | 2 b | 1.5 b | 1.4 b | 1.6 b | 1.5 b | 1.4 b | 1.5 b |
Gross profit | 1.9 b | 2 b | 2 b | 2.1 b | 1.8 b | 1.9 b | 1 b | 965 m | 972 m | 1.1 b | 1 b | 1.1 b |
Gross profit Margin, % | 52% | 50% | 48% | 49% | 48% | 49% | 42% | 41% | 38% | 42% | 42% | 43% |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 2.7 b | 2.9 b | 2.2 b | 2.8 b |
Inventories | 3.5 b | 3.6 b | 1.6 b | 1.4 b |
Current Assets | 10 b | 10.4 b | 11.8 b | 6.6 b |
PP&E | 7.8 b | 8.7 b | 4.4 b | 4.3 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 2.4 b | 2 b | 1.9 b | 2.1 b | 2.5 b | 6.7 b | 2 b | 2.2 b | 2.6 b | 2.6 b | 2.9 b | 3.8 b |
Inventories | 3.6 b | 3.7 b | 3.8 b | 3.7 b | 3.5 b | 3.8 b | 1.7 b | 1.7 b | 1.6 b | 1.6 b | 1.5 b | 1.5 b |
Current Assets | 9.6 b | 9.4 b | 9.5 b | 9.6 b | 9.7 b | 14.5 b | 11.1 b | 8 b | 6.8 b | 6.6 b | 6.6 b | 7.7 b |
PP&E | 7.5 b | 8 b | 8.2 b | 8.4 b | 8.5 b | 9 b | 4.3 b | 4.4 b | 4.3 b | 4.3 b | 4.3 b | 4.3 b |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 2 b | 2.5 b | 968 m | 5 b |
Inventories | (311 m) | (439 m) | 1.6 b | 80 m |
Cash From Operating Activities | 2.2 b | 3.2 b | 1.8 b | 1.7 b |
Cash From Investing Activities | 5.4 b | (1.5 b) | (1.8 b) | (715 m) |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 544 m | 556 m | 520 m | 468 m | 430 m | 762 m | 763 m | 3.4 b | 4.6 b | 4.7 b | 272 m | 537 m |
Depreciation and Amortization | 497 m | 593 m | 189 m | 395 m | 599 m | 194 m | 378 m | |||||
Inventories | (439 m) | (205 m) | (26 m) | (25 m) | (11 m) | (29 m) | (38 m) | |||||
Income Taxes Paid | 429 m | 345 m | 453 m |
| USD | Y, 2017 |
|---|---|
Revenue/Employee | 54.3 k |
Financial Leverage | 1.9 x |
Report incorrect company information
